Literature DB >> 20538130

Comparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate to severe heart failure.

Djordje G Jakovljevic1, Robert S George, Gay Donovan, David Nunan, Keiran Henderson, Robert S Bougard, Magdi H Yacoub, Emma J Birks, David A Brodie.   

Abstract

Peak cardiac power output (CPO), as a direct measurement of overall cardiac function, has been shown to be a most powerful predictor of prognosis for patients with chronic heart failure. The present study assessed CPO and exercise performance in patients implanted with a left ventricular assist device (LVAD), those explanted due to myocardial recovery, and those with moderate to severe heart failure. Hemodynamic and respiratory gas exchange measurements were undertaken at rest and at peak graded exercise. These were performed in 54 patients-20 with moderate to severe heart failure, 18 with implanted LVADs, and 16 with explanted LVADs. At rest there was a nonsignificant difference in CPO among groups (p >0.05). Peak CPO was significantly higher in the explanted LVAD than in the heart failure and implanted LVAD groups (heart failure 1.90 +/- 0.45 W, implanted LVAD 2.37 +/- 0.55 W, explanted LVAD 3.39 +/- 0.61 W, p <0.01) as was peak cardiac output (heart failure 9.1 +/- 2.1 L/min, implanted LVAD 12.4 +/- 2.2 L/min, explanted LVD 14.6 +/- 2.9 L/min, p <0.01). Peak oxygen consumption was higher in the explanted LVAD than in the heart failure and implanted LVAD groups (heart failure 15.8 +/- 4.1 ml/kg/min, implanted LVAD 19.8 +/- 5.8 ml/kg/min, explanted LVAD 28.2 +/- 5.0 ml/kg/min, p <0.05) as was anaerobic threshold (heart failure 11.2 +/- 1.9 ml/kg/min, implanted LVAD 14.7 +/- 4.9 ml/kg/min, explanted LVAD 21.4 +/- 5.0 ml/kg/min, p <0.05). In conclusion, peak CPO differentiates well during cardiac restoration using LVADs and emphasizes the benefits of this therapy. CPO has the potential to be a key physiologic marker of heart failure severity and can guide management of patients with LVAD.

Entities:  

Mesh:

Year:  2010        PMID: 20538130     DOI: 10.1016/j.amjcard.2010.01.362

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement.

Authors:  Christos P Kyriakopoulos; Chris J Kapelios; Elizabeth L Stauder; Iosif Taleb; Rana Hamouche; Konstantinos Sideris; Antigone G Koliopoulou; Michael J Bonios; Stavros G Drakos
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

2.  In Vivo Evaluation of a Physiologic Control System for Rotary Blood Pumps Based on the Left Ventricular Pressure-Volume Loop.

Authors:  Joshua Cysyk; Choon-Sik Jhun; Ray Newswanger; Walter Pae; Jenelle Izer; Heidi Flory; John Reibson; William Weiss; Gerson Rosenberg
Journal:  ASAIO J       Date:  2022-12-01       Impact factor: 3.826

3.  Cannula Tip With Integrated Volume Sensor for Rotary Blood Pump Control: Early-Stage Development.

Authors:  Joshua Cysyk; Ray Newswanger; Eric Popjes; Walter Pae; Choon-Sik Jhun; Jenelle Izer; William Weiss; Gerson Rosenberg
Journal:  ASAIO J       Date:  2019 May/Jun       Impact factor: 2.872

4.  Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients.

Authors:  Jodi McCoy; Matthew Bates; Christopher Eggett; Mario Siervo; Sophie Cassidy; Jane Newman; Sarah A Moore; Grainne Gorman; Michael I Trenell; Lazar Velicki; Petar M Seferovic; John G F Cleland; Guy A MacGowan; Doug M Turnbull; Djordje G Jakovljevic
Journal:  Open Heart       Date:  2017-07-28

5.  Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.

Authors:  Djordje G Jakovljevic; Magdi H Yacoub; Stephan Schueler; Guy A MacGowan; Lazar Velicki; Petar M Seferovic; Sandeep Hothi; Bing-Hsiean Tzeng; David A Brodie; Emma Birks; Lip-Bun Tan
Journal:  J Am Coll Cardiol       Date:  2017-04-18       Impact factor: 24.094

6.  NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.

Authors:  Milos Parovic; Nduka C Okwose; Kristian Bailey; Lazar Velicki; Zlatko Fras; Petar M Seferovic; Guy A MacGowan; Djordje G Jakovljevic
Journal:  ESC Heart Fail       Date:  2019-02-20

7.  Left ventricular support adjustment to aortic valve opening with analysis of exercise capacity.

Authors:  Daniele Camboni; Tobias J Lange; Patrycja Ganslmeier; Stephan Hirt; Bernhard Flörchinger; York Zausig; Leopold Rupprecht; Michael Hilker; Christof Schmid
Journal:  J Cardiothorac Surg       Date:  2014-05-20       Impact factor: 1.637

8.  The effect of age on the relationship between cardiac and vascular function.

Authors:  David Houghton; Thomas W Jones; Sophie Cassidy; Mario Siervo; Guy A MacGowan; Michael I Trenell; Djordje G Jakovljevic
Journal:  Mech Ageing Dev       Date:  2015-11-15       Impact factor: 5.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.